Loading clinical trials...
Loading clinical trials...
The main aim of this study is to describe the treatment patterns, characteristics and outcomes of people with HAE who are currently receiving icatibant in the homecare setting in the United Kingdom (U...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Takeda
NCT06679881 · Hereditary Angioedema (HAE)
NCT07298447 · Hereditary Angioedema (HAE)
NCT06842823 · Hereditary Angioedema (HAE)
NCT07046806 · Hereditary Angioedema (HAE), Angioedema, and more
NCT05396105 · Hereditary Angioedema, Hereditary Angioedema Type I, and more
Sciensus
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions